COVID-19 in decompensated cirrhosis
- 29 September 2020
- journal article
- letter
- Published by Springer Science and Business Media LLC in Hepatology International
- Vol. 14 (6), 1125-1127
- https://doi.org/10.1007/s12072-020-10092-4
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- High mortality rates for SARS-CoV-2 infection in patients with pre-existing chronic liver disease and cirrhosis: Preliminary results from an international registryJournal of Hepatology, 2020
- COVID-19 and the liverJournal of Hepatology, 2020
- SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19Journal of Hepatology, 2020
- Clinical Characteristics of Coronavirus Disease 2019 in ChinaThe New England Journal of Medicine, 2020
- Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, ItalyJAMA, 2020
- Critical Care Utilization for the COVID-19 Outbreak in Lombardy, ItalyJAMA, 2020
- Central nervous system manifestations of COVID-19: A systematic reviewJournal of the Neurological Sciences, 2020